Figure 3From: Targeting CEA in Pancreas Cancer Xenografts with a Mutated scFv-Fc Antibody Fragment Representative slides of IHC staining with anti-CEA scFv-Fc (H310A) antibody of different tissue specimens. At ×40 magnification, (a) human pancreas cancer with strong staining, (b) human pancreas cancer with moderate staining, (c) human pancreas cancer with weak staining, (d) mouse pancreas cancer xenograft, (e) normal human pancreas, and (f) normal human liver.Back to article page